Neurotrophins in Skin Biology and Pathology  by Botchkarev, Vladimir A. et al.
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Alessandra Marconi5, Smriti K. Raychaudhuri3, Ralf Paus6 and Carlo Pincelli5
Neurotrophins (NTs) belong to a family of growth factors, which control the development, maintenance, and
apoptotic death of neurons and also fulfill multiple regulatory functions outside the nervous system. Biological
effects induced by NTs strongly depend on the pattern of NT receptor/co-receptors expression in target cells, as
well as on the set of intracellular adaptor molecules that link NT signalling to distinct biochemical pathways. In
this review, we summarize data on the molecular mechanisms underlying the involvement of NTs in the control
of non-neuronal functions in normal skin (e.g. keratinocyte proliferation, melanocyte development and
apoptosis, hair growth). We also review the data on the role for NTs and their receptors in a number of
pathological skin conditions (stress-induced hair loss, psoriasis, atopic dermatitis). Although additional efforts
are required to fully understand mechanisms underlying the involvement of NTs and their receptors in
controlling functions of normal and pathologically altered skin cells, substantial evidence suggests that
modulation of NT signalling by NTs receptor agonists/antagonists may be developed as intervention modalities
in distinct skin and hair growth pathologies.
Journal of Investigative Dermatology (2006) 126, 1719–1727. doi:10.1038/sj.jid.5700270
Introduction
The common ectodermal origin of
nervous system and skin epithelium
suggests that growth factors regulating
the development and function of neu-
rons are also involved in the control of
skin homeostasis and remodelling
(Paus et al., 1997; Pincelli and Yaar,
1997; Yaar, 1999; Botchkarev et al.,
2004). In this context, neurotrophins
(NTs) are particularly important and
fascinating study objects, as – as target-
derived growth factors – they play an
essential role in neuronal development,
survival, outgrowth, and in the selec-
tive elimination of distinct neuronal
sub-populations by apoptosis (Teng
and Hempstead, 2004). Furthermore,
it is well accepted now that, besides
their involvement in the control of
neuronal development, NTs together
with other neurotrophic factors (e.g.
ciliary-neurotrophic factor, glial cell
line-derived neurotrophic factor) fulfill
multiple non-neuronal functions and
regulate cell proliferation, differentia-
tion, apoptosis, and tissue remodelling
outside of the nervous system (Sariola,
2001; Aloe, 2004).
During the last decade, substantial
progress has been achieved in defining
the roles for NTs and their receptors in
the control of skin homeostasis and
hair growth (for a review, see Paus
et al., 1997; Pincelli and Yaar, 1997;
Yaar, 1999; Bonini et al., 2003;
Botchkarev et al., 2004). Here, we
review the molecular mechanisms
underlying the involvement of NTs in
the control of non-neuronal functions
in normal skin, as well as the role for
NTs in a number of pathological
skin conditions, focusing on stress-
induced hair loss, psoriasis, and atopic
dermatitis. We also provide evidence
that modulation of NT signalling by
NT receptor agonists/antagonists may
be used as a novel approach for
managing distinct skin and hair growth
abnormalities.
NTs and their receptors
The NT family consists of four structu-
rally and functionally related proteins:
nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3), and neurotro-
phin-4 (NT-4). All four members of the
NT family are synthesized as precur-
sors, which are cleaved by intracellular
proteases to release the C-terminal
mature proteins (reviewed in Teng
and Hempstead, 2004). Mature NT
proteins are approximately 13 kDa in
size, share about 50% of amino-acid
sequence homology, and exert their
biological effects as dimers interacting
with specific receptors (for a review,
see Huang and Reichardt, 2001). High-
affinity receptors for NTs belong to the
tyrosine kinase family: tyrosine kinase
receptor A (TrkA) is the high-affinity
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receptor for NGF, tyrosine kinase re-
ceptor B (TrkB) is the high-affinity
receptor for BDNF and NT-4, and
tyrosine kinase receptor C (TrkC) is
the high-affinity receptor for NT-3
(Segal, 2003). However, NT-3 may also
bind – with low affinity – to TrkA and
TrkB receptors. All four NTs interact
with the low-affinity p75 kDa NT re-
ceptor (p75NTR), which is a member of
the tumor necrosis factor family of
receptors containing the cytoplasmic
‘‘death’’ domain, involved in mediating
a number of responses independently
or in association with Trk receptors (for
a review, see Dechant and Barde,
2002; Roux and Barker, 2002; Teng
and Hempstead, 2004).
By interacting with Trk receptors
and/or p75NTR, NTs induce a variety
of biological reactions in neurons and
non-neuronal cells and control prolif-
eration, differentiation, and survival
(Table 1). The signals promoting survi-
val or differentiation are generated by
NT interaction with Trk receptors and
require receptor dimerization, auto-
phosphorylation, and the subsequent
involvement of a number of adaptor
molecules coupling Trk receptors to the
distinct intracellular signal transduction
pathways (Segal, 2003). NTs modulate
synaptic transmission via Trk-asso-
ciated regulation of intracellular
Ca2þ , promote survival via phosphor-
ylation and inactivation of several
proapoptotic substrates including Bad,
as well as promote differentiation via
activation of the Ras/Raf/ERK kinse/
mitogen-activated protein kinase cas-
cade (reviewed in Segal, 2003).
p75NTR fulfils distinct functions
depending on whether it is co-
expressed with Trk receptors and/or
selected other growth factor receptors
(sortilin, Nogo receptor complex), or
whether it is expressed alone (Table 1).
The co-expression of p75NTR with Trk
receptors increases high-affinity NT
binding, enhances Trk ability to dis-
criminate a preferred ligand from the
other NTs, and promotes survival ef-
fects of the NTs (Dechant and Barde,
2002; Roux and Barker, 2002; Teng
and Hempstead, 2004). When p75NTR
is co-expressed with sortilin (a non-G-
protein-coupled neurotensin receptor),
NT precursor proteins (pro-NTs) inter-
acting with p75NTR–sortilin complex
induce apoptotic death (reviewed in
Nykjaer et al., 2005). In case of co-
expression of p75NTR with the Nogo
receptor complex, Nogo induces
growth inhibition (reviewed in Teng
and Hempstead, 2004).
When p75NTR is expressed alone
on the cell surface, mature NT pep-
tides or selected non-NT ligands (beta-
amyloid or a fragment of the prion
protein) are capable of inducing apop-
tosis or promote survival depending on
the intracellular adaptor molecules
present in target cells (Yaar et al.,
2002; Teng and Hempstead, 2004).
Apoptotic signalling via p75NTR re-
quires the presence of intracellular
adaptor molecules (NT receptor-inter-
acting factors 1 and 2, NT receptor-
interacting MAGE homolog, and NT-
associated death executor) that link
p75NTR signalling with the JNK-p53-
Bax proapoptotic pathway (Table 1).
However, signalling through p75NTR
expressed alone – besides inducing
apoptosis – may also promote cell
survival. Intracellular adaptor mole-
cules interacting with the C-terminus
of p75NTR (TNF receptor-associated
factor 6, Fas-associated phosphatase-1,
and receptor interacting protein-2)
link p75NTR with the NF-kB pathway
and can thus promote survival
(Roux and Barker, 2002). However,
mechanisms involved in the controlling
the expression and preferential
engagement of adaptor molecules in
distinct cell types remain to be clar-
ified. These growing, ever more com-
plex insights into NT-mediated
signalling must be kept in mind when
interpreting the data obtained so far on
the effects of NTs in distinct skin cell
populations.
Non-neuronal targets for NTs in the skin
In mice, NTs are expressed very early
during embryonic development
(E9.5–E10.5) in both the skin epithelium
and the cutaneous mesenchyme
(reviewed in Ernfors et al., 1994). The
onset of NT expression in embryonic
Table 1. Biochemical components of the distinct signalling pathways activated by NTs and their receptors1
Ligand(s) Receptor(s) Co-receptor(s)
Intracellular adaptor
molecule(s)
Intracellular signaling
pathway(s)
Biological
effect(s)
NGF, BDNF, NT-3, NT-4 Trk A, Trk B, or TrkC p75NTR Shc, Grb2, Gab-1 PI3K/PKB/AKT Survival
NGF, BDNF, NT-3, NT-4 Trk A, Trk B, or TrkC p75NTR or none Shc, Grb2, SOS, ARMS, Ras, Raf Ras/Raf/MEK/MAPK Differentiation
NGF, BDNF, NT-3, NT-4 Trk A, Trk B, or TrkC p75NTR PLC-g IP3/DAG Ca2+ release
NGF, BDNF, NT-3, NT-4 p75NTR — TRAF6, FAP-1, RIP-2 NF-kB Survival
NGF, BDNF, NT-3, NT-4 p75NTR — NRIF1/2, NRAGE, NADE Jnk, p53, Bax, caspases
9/6/3
Apoptosis
Pro-NGF p75NTR Sortilin ND ND Apoptosis
Nogo p75NTR Nogo receptor,
Lingo-1
ND ND Growth
inhibition
1For details, see the corresponding review articles (Dechant and Barde, 2002; Roux and Barker, 2002; Segal, 2003; Teng and Hempstead, 2004; Nykjaer
et al., 2005).
JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MEK, ERK kinse; NADE, neurotrophin-associated death executor; NRAGE,
neurotrophin receptor interacting MAGE homolog; NRIF1/2, neurotrophin receptor-interacting factors 1 and 2; ND, not determined; PKB, protein kinase B;
PI3K, phosphatidylinositol 30-kinase; PLC, phospholipase C.
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skin coincides with the time point of
appearance of K5 and K14 in the
epidermis (E9.5), whereas maximal
NT synthesis coincides with the begin-
ning of vibrissa development in facial
skin (E12.5), and with the initiation of
tylotrich hair follicle (HF) induction in
dorsal murine skin (E14.5) (Ernfors
et al., 1994). This suggests the hypo-
thesis that NTs fulfill multiple non-
neurotrophic functions during skin
development.
In postnatal skin, NTs and their
receptors are differentially distributed
in distinct cell populations (Figure
1a–c). Basal epidermal keratinocytes
in humans and mice express NGF and
NT-4 (Di Marco et al., 1991, 1993;
Pincelli et al., 1994, 1997; Botchkarev
et al., 1999). NGF, NT-3, and BDNF
are produced by fibroblasts in vitro,
and NGF stimulates fibroblast migra-
tion (reviewed in Yaar, 1999). In situ,
BDNF and NT-3 are expressed in
cutaneous nerve fibers and myocytes
of the arrector pili and panniculus
carnosus muscles (Botchkarev et al.,
1999). All four NT receptors (TrkA,
TrkB, TrkC, and p75NTR) have been
detected on human epidermal kerati-
nocytes (Bronzetti et al., 1996; Grewe
et al., 2000). In murine skin, only TrkA
and TrkB isoforms are seen in epider-
mal keratinocytes, whereas TrkC and
p75NTR are expressed in cutaneous
nerves and in the HF (Botchkarev et al.,
1999).
NTs and epidermal keratinocytes
Work over the past 10 years has
indicated that NTs possess a range of
functions outside the nervous system
(Sariola, 2001; Bonini et al., 2003;
Aloe, 2004) and can be considered as
growth factors in epithelial tissue home-
ostasis. It was demonstrated that normal
human keratinocytes synthesize and
secrete biologically active NGF (Di
Marco et al., 1991; Yaar et al., 1991).
In human skin, NGF is released in
increasing amounts by proliferating
keratinocytes, whereas secretion ends
in more differentiated cells (Pincelli
et al., 1994; Stefanato et al., 2003;
Figure 1d). Both exogenous and endo-
genous NGF are capable of inducing
keratinocyte proliferation (Di Marco
et al., 1993). On the other hand, in
the presence of their normal mesen-
chymal environment, exogenous NGF
can indeed either stimulate or inhibit
murine epidermal and HF keratinocyte
proliferation in situ, depending on
whether the keratinocytes are in a state
of relative quiescence or are already
maximally proliferating (Paus et al.,
1994). The proliferative effects of auto-
crine NGF on human keratinocytes are
also confirmed by the use of the natural
alkaloid K252a, an inhibitor of TrkA
phosphorylation. Indeed, K252 blocks
keratinocyte proliferation, in the ab-
sence of exogenous NGF (Pincelli et al.,
1994). Moreover, human keratinocytes
transfected with NGF proliferate to a
significantly greater extent than mock-
transfected cells (Marconi et al., 1999).
Keratinocytes express and release
NTs, other than NGF (Botchkarev
et al., 1999; Marconi et al., 2003),
and BDNF, NT-3, and NT-4 stimulate
murine epidermal keratinocyte proli-
feration in situ (Botchkarev et al.,
1999). NGF is secreted at highest levels
as compared to the other NTs, whereas
NT-3 and NGF upregulate each other’s
secretion in human keratinocytes. NGF
expression is downregulated by UVB
irradiation (Marconi et al., 1999; Stefa-
nato et al., 2003), whereas NT-3
release is augmented by UVA.
At the skin level, TrkA and TrkC
mediate NGF- and NT-3-induced kera-
tinocyte proliferation, respectively. In-
deed, keratinocytes overexpressing
TrkA proliferate significantly better
than controls (Pincelli, 2000), and
increasing concentrations of anti-NT-3
antibody inhibit keratinocyte prolifera-
tion (Marconi et al., 2003). In mouse
skin, epidermal keratinocytes express
TrkA and TrkB, and all NTs are capable
of stimulating their proliferation in ex
vivo-cultured skin explants (Paus et al.,
1994; Botchkarev et al., 1999).
Apoptosis plays a fundamental role
in epidermal homeostasis by counter-
balancing cell proliferation, and apop-
totic cells are consistently present in
normal human epidermis (Pincelli
et al., 1997; Wehrli et al., 2000). In
vitro, NGF, but not the other NTs, can
rescue human epidermal keratinocytes
from spontaneous and UVB-induced
apoptosis via TrkA (Pincelli et al.,
1997; Marconi et al., 1999, 2003).
Although UVB downregulates NGF
and TrkA in human keratinocytes,
NGF-overexpressing keratinocytes are
protected from UVB-induced apoptosis
(Marconi et al., 1999).
NGF protects keratinocytes from
cell death via the Bcl-2 family of
apoptosis inhibitors. Indeed, K252a
fails to induce apoptosis in keratino-
cytes overexpressing Bcl-2, and UVB
causes a decrease in Bcl-2 and Bcl-xL
expression in mock-transfected kerati-
nocytes, but not in NGF-overexpressing
cells. NGF prevents the cleavage of the
enzyme poly(ADP-ribose) polymerase,
a substrate for caspases, that is induced
in human keratinocytes by UVB
NGF
NGF
TrkA
TrkA
p75NTR
p75NTR
a
d
b
e
c
f
Figure 1. Expression of NTs and their receptors in mouse and human skin. Cryostat sections of mouse
and human skin were immunostained with antisera to NGF, TrkA, and p75NTR. (a–c) Mouse embryonic
skin. (a) NGF and (b) TrkA expression in basal layer of epidermis (arrowheads) and hair placodes (arrows)
in embryonic mouse skin. (c) p75NTR expression in the mesenchyme of developing HFs (arrows) and in
Schwann cells (arrowheads) in embryonic mouse skin. (d–f) Human adult skin. (d) NGF is expressed in
suprabasal keratinocytes (arrows) and in single cells of the basal epidermal layer (arrowhead). (e) TrkA
expression in basal epidermal keratinoicytes (arrows). (f) p75NTR expression in basal epidermal
keratinocytes with predominance in the inter-rete areas (arrows) and in cutaneous nerve fibers/Schwann
cells (arrowheads).
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(Marconi et al., 1999). These results are
consistent with a model whereby auto-
crine NGF protects human keratino-
cytes from apoptosis through its high-
affinity receptor TrkA by maintaining
constant levels of Bcl-2 and Bcl-xL,
which in turn block caspase activation.
The above-mentioned data clearly
show that NTs mediate proliferative
and survival signals in epidermal kera-
tinocytes through their high-affinity Trk
receptors. Still, the role of the low-
affinity p75NTR in NGF signalling in
keratinocytes remains to be clarifed.
Although TrkA is evenly distributed in
the basal keratinocyte layer, p75NTR is
expressed in basal keratinocytes with
an irregular pattern (Figure 1e and f). As
human keratinocytes lack functional
TrkB (Marconi et al., 2003), BDNF
and NT-4 obviously signal through
p75NTR in these cells. Indeed, BDNF
and NT-4 induce apoptosis in cultured
human keratinocytes (Atzei et al.,
manuscript in preparation). This is in
agreement with the observation of a
similar function of p75NTR in the
catagen phase of the hair cycle (Botch-
karev et al., 2000). Therefore, a
balance between the low- and the
high-affinity NT receptors exists in
keratinocytes. However, the exact
stimuli and conditions whereby NGF
and other NTs signal life or death in
keratinocytes are yet to be defined.
Also, it remains to be determined
whether NTs and their receptors could
play a role in the development of non-
melanoma skin cancers by stimulating
proliferation and inhibiting apoptosis,
in a manner similar to what has been
shown for prostate (Krygier and
Djakiew, 2001) and breast neoplasia
(reviewed in Nakagarawa, 2001).
NTs and melanocytes
During skin development, neural crest-
derived melanoblasts migrate into the
skin and differentiate into melanocytes,
which populate the basal layer of the
epidermis and the HFs. Together with
other paracrine signalling molecules
(fibroblast growth factor (FGF), bone
morphogenetic proteins, noelin-1, stem
cell factor, hepatocyte growth factor,
endothelins), NTs play an important
role in the control of melanoblast
migration, viability, and differentiation
(reviewed in Pincelli and Yaar, 1997;
Yaar, 1999).
Normal human melanocytes also
express p75NTR and its expression
level is upregulated by a variety
of stimuli including UV irradiation
(Peacocke et al., 1988). Keratinocyte-
derived NGF, which expression is also
upregulated by UV irradiation (Di
Marco et al., 1991; Yaar et al., 1991),
may influence epidermal melanocytes
in a paracrine manner. In vitro, NGF is
chemotactic for melanocytes and sti-
mulates melanocyte dendrite formation
(Yaar et al., 1991). Although under
optimal basal culture conditions, there
is no effect of NGF on melanocyte cell
yields or melanogenesis, both NGF and
NT-3, the latter expressed by dermal
fibroblasts (Yaar et al., 1994), increase
melanocyte survival when the cells are
maintained in medium depleted of
growth factors (Yaar et al., 1994; Zhai
et al., 1996).
Interestingly, phorbol 12-tetra decan-
oate 13 acetate, a strong activator of
protein kinase C, upregulates the expres-
sion of p75NTR and induces the expres-
sion of TrkA in melanocytes (Yaar et al.,
1994). Although the exact mechanism
that regulates phorbol 12-tetra decano-
ate 13 acetate-induced p75NTR and
TrkA upregulation is not known, phorbol
12-tetra decanoate 13 acetate is recog-
nized to have a striking effect also on
melanocyte dendricity. It is possible that
this differentiated morphology of mela-
nocytes is part of an integrated complex
of differentiated functions that includes
induction of receptors to NGF. In con-
trast with TrkA expression that requires
induction, melanocytes constitutively
express TrkC, albeit the expression is
likely to be low as it was detected by the
sensitive reverse transcriptase-PCR
methodology (Yaar et al., 1994). Also,
in contrast with TrkA expression, TrkC
expression is decreased after phorbol
12-tetra decanoate 13 acetate, suggest-
ing that although melanocytes can bind
both NGF and NT-3, different signals
that preferentially induce a specific high-
affinity receptor determine which NT
would exert its effect. Thus, NGF and
NT-3 effect in melanocytes may be
influenced by outside signals through
modulations of their high-affinity recep-
tor expression.
Indeed, using UV-irradiated cul-
tured melanocytes and human mela-
noma cells, NGF supplementation en-
hances cell survival, markedly reduces
apoptotic cell death, and increases the
level of the antiapoptotic Bcl-2 protein
which is expressed strongly by mela-
nocytes in vivo even in the absence of
UV irradiation (Zhai et al., 1996;
Stefanato et al., 2003). The data suggest
that NGF, which is constitutively pro-
duced by neighboring epidermal kera-
tinocytes, may preserve the population
of cutaneous melanocytes that would
otherwise be depleted by sun-expo-
sure. In contrast, NT-3, which is
strongly expressed by non-proliferating
fibroblasts (Yaar et al., 1994), like those
in the dermal compartment of non-
damaged human skin, could help in
melanocyte maintenance during stea-
dy-state conditions.
NTs in the control of HF development
and cycling
The HF is an unusually densely inner-
vated peripheral organ, whose devel-
opment is governed by epithelio-
mesenchymal interactions between
epidermal keratinocytes committed to
HF-specific differentiation and a cluster
of dermal cells that form the follicular
papilla (Schmidt-Ullrich and Paus,
2005). In postnatal life, HF transits
through its lifelong cycle of growth
(anagen) to apoptosis-driven regression
(catagen) and finally relative resting
(telogen) (Stenn and Paus, 2001). As
the role for NTs and their receptors in
the regulation of HF development and
cycling were recently reviewed in de-
tails elsewhere (Botchkarev et al.,
2004), we will only briefly summarize
the most important aspects of NT
involvement in hair growth control.
During skin development, intracuta-
neously generated NTs are not only
required for appropriate skin innerva-
tion but also play an important role in
the control of HF morphogenesis. This
is evident from the observation that
murine HFs show developmentally and
spatiotemporally stringently controlled
expression of NTs and their cognate
receptors (TrkA, TrkB, TrkC, p75NTR;
Figure 1a–c) (Botchkarev et al., 1998;
Botchkareva et al., 1999, 2000).
Furthermore, data obtained from
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genetically engineered mice with
constitutive overexpression or deletion
of NGF, BDNF, and/or NT-3/TrkC
revealed that NGF and NT-3 signifi-
cantly accelerate HF morphogenesis,
whereas BDNF do not show any
significant effects (Botchkarev et al.,
1998, 2004; Botchkareva et al., 2000).
In contrast to Trk receptor signalling,
p75NTR that is expressed in the folli-
cular papilla plays an inhibitory role
during murine HF morphogenesis
(Botchkareva et al., 1999). Compared
to age-matched wild-type animals,
p75NTR knockout (/) mice showed
a significant acceleration of HF develop-
ment associated with increased expres-
sion of FGF-2 receptor (FGFR-2) that
specifically binds to FGF7/KGF, in the
dermal papilla and outer root sheath
(Botchkareva et al., 1999). As the
acceleration of HF development in
p75NTR knockout mice could be over-
come by administration of FGF7-neu-
tralizing antibody, this suggests that, in
developing murine HF, p75NTR down-
regulates FGF7-signalling through
FGFR-2 and thus acts as a ‘‘brake’’ on
HF morphogenesis by limiting the ef-
fects of FGF7 on early steps of HF
development (Botchkareva et al., 1999).
During later HF cycling, follicular
NTs and NT receptor expression dis-
play hair cycle-dependent fluctuations
on the mRNA and protein level, which
are mirrored by changes in nerve fiber
density and neurotransmitter/neuro-
peptide content in the perifollicular
neural networks (reviewed in Botchkar-
ev et al., 2004). During the murine hair
cycle, steady-state levels of NGF and
NT-3 proteins fluctuate differently:
while NGF levels rise dramatically in
early anagen skin, NT-3 protein was
significantly upregulated during cata-
gen. Also, the steady-state levels of NT-
3, BDNF, and NT-4 mRNAs were
significantly increased prior and during
catagen onset (reviewed in Botchkarev
et al., 2004). Furthermore, neonatal
transgenic mice overexpressing NGF,
NT-3, or BDNF display accelerated
catagen development, and BDNF-over-
expressing mice have a significant
shortening of hair length compared to
the corresponding age-matched wild-
type animals. Conversely, NT-3,
BDNF, or NT-4 null mutants show
catagen retardation (Botchkarev et al.,
2004).
The addition of NGF, NT-3, NT-4,
and BDNF in vitro significantly stimu-
late catagen development in C57BL/6
murine skin organ cultures, whereas
p75NTR antagonist cyclic decapeptide
abrogates catagen-stimulatory effects
of NTs and retards catagen in situ
(Botchkarev et al., 2000, 2004;
Peters et al., 2006). By using p75NTR
knockout mice, we showed that cata-
gen-stimulatory effects of NTs is
mediated by their binding via p75NTR
expressed in keratinocytes of the re-
gressing outer root sheath (Botchkarev
et al., 2000).
In cultured human anagen HFs,
NGF and BDNF suffice to induce
premature entry into a catagen-like
stage (Peters et al., 2005, 2006), which
can be antagonized by transforming
growth factor-b2- or p75NTR-neutraliz-
ing antibodies. Interestingly, the newly
discovered high-affinity ligand for
p75NTR, pro-NGF, is present in the
terminally differentiated inner root
sheath of human anagen HFs and is
upregulated in the same apoptosis-rich
compartments as p75NTR during spon-
taneous catagen-like regression of hu-
man anagen HFs (Peters et al., 2006),
suggesting that both NGF and pro-NGF
are involved in controlling apoptosis in
human HF keratinocytes.
Taken together, these data suggest
that the HF serves as both a prominent
target and key peripheral source of NTs
in the skin, and that appropriate NT
receptor ligands could be used not only
for treating unwanted hair loss (alo-
pecia, effluvium) but also for the
management of excessive, unwanted
hair growth (hirsutism, hypertrichosis).
Immunomodulatory functions of NTs in
the skin
Numerous publications suggest that
NTs play an important role in regulat-
ing the activity of immune cells in
normal skin and in a number of
pathological conditions including
wound healing, inflammation, psoria-
sis, and atopic dermatitis, as well as in
the allergic, autoimmune, and stress-
induced skin responses (reviewed in
Ansel et al., 1997; Legat et al., 2002;
Steinhoff et al., 2003; see also below).
In normal skin (see Figure 2), mast
cells, endothelial cells, and macro-
phages express NGF, whereas TrkA
receptor is expressed on mast cells
and endothelial cells (Raychaudhuri
and Raychaudhuri, 2004; Groneberg
et al., 2005; Raap and Kapp, 2005).
Similarly to other organs, NGF
stimulates degranulation and cytokine
release from skin mast cells and there-
by promotes neurogenic inflammation
(reviewed in Legat et al., 2002; Steinh-
off et al., 2003). During inflammation,
NGF stimulates tissue nociceptors and
enhances inflammatory pain, as well
as increases vascular permeability
followed by tissue edema via stimu-
lation of calcitonin gene-related
peptide release from sensory nerve
endings and via induction of mast cell
Stimulation of proliferation 
and inhibition of apoptosis 
via binding Trk receptors; 
proapoptotic effects via 
binding p75NTR expressed 
alone
Stimulation of chemotactic 
activity, dendrite formation, 
inhibition of apoptosis via 
binding Trk receptors
Regulation of development,
maintenance of survival
Stimulation of migration
Stimulation of 
degranulation, cytokine 
release, inhibition of 
apoptosis
Stimulation of proliferation,
expresion of adhesion 
molecules
Keratinocytes
TrkA, TrkB, TrkC, 
p75NTR, Sortilin
Melanocytes
TrkA, TrkC, p75NTR
Merkel cells
TrkC, p75NTR
Fibroblasts
TrkC, p75NTR
Neutrophins 
NGF, BDNF,
NT-3, NT-4
Mast cells
TrkA, p75NTR
Endothelial cells
TrkA
Figure 2. Scheme illustrating the effects of NTs on distinct cell populations in skin.
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degranulation (Aloe, 2004). However,
mast cell-derived NGF may also play a
role in establishing the contacts be-
tween mast cells and sensory nerve
fibers in normal skin, which frequency
fluctuates significantly in a hair cycle-
dependent manner (reviewed in Botch-
karev et al., 2004). Such contacts are a
prerequisite of the increased mast cell
degranulation observed upon stress-
exposure (Peters et al., 2005c) and
increase in number under stress, which
upstream of substance P (SP) may
also be responsible for the increased
SP-induced neurogenic inflammation
observed upon stress-exposure (Peters
et al., 2004).
In addition to the regulation of these
inert immune responses, NGF is in-
volved in the activation, migration, and
proliferation of endothelial cells, lym-
phocytes, and macrophages in the skin,
as well as in the expression of adhesion
molecules on endothelial cells, thus
implicating its role in controlling the
traffic of blood cells into the skin and in
the promotion of a specific immune
response and cytokine production with
implications for chronic inflammatory,
allergic, and autoimmune diseases
(Raychaudhuri et al., 2001; Raap and
Kapp, 2005). However, although NTs
are involved in the control of lympho-
cyte development and T-lymphocytes
are capable of producing NGF and
BDNF (for a review, see Vega et al.,
2003), only little is known about the
expression of NTs and their receptors
on distinct lymphocyte subpopulations
in normal and diseased skin.
NTs in pathological skin conditions
Increasing evidence suggests that NTs
are also involved in the pathogenesis of
inflammatory skin diseases character-
ized either by cell loss (stress-induced
alopecia) or hyperproliferation (inflam-
mation, wound healing, psoriasis,
atopic dermatitis) via neurogenic
inflammatory processes or by inducing
a misbalance in cytokine production
and autoimmune responses. As the role
of NTs in pathogenesis of the inflam-
matory response and wound healing
has been reviewed elsewhere (Bonini
et al., 2003; Kawamoto and Matsuda,
2004), here we shall only sketch some
recently emerging concepts on the role
of NTs in stress-induced hair loss,
atopic dermatitis, and psoriasis.
NTs in the HF response to psychoemo-
tional stress. It has been shown that
upon acute stress-exposure, NGF is
released into the blood, for example,
from submaxillary glands of male mice
(cf. Alleva et al., 1996) and perhaps
other sources, making it a likely med-
iator of stress. The role of NGF as a
local stress-response mediator involved
in neurogenic inflammation was also
recently established in a mouse model
for perceived psychoemotional stress
(Arck et al., 2001; Peters et al., 2004,
Paus et al., 2006). In this model, stress-
induced increase in the numbers of
apoptotic cells in the HF can be
antagonized by NGF neutralization
(Peters et al., 2004), demonstrating an
important role for NGF in stress-
induced HF damage. Remarkably,
NGF serves as a trigger that mediates
a complex skin and HF responses to
stress involving in addition neuropep-
tides released from sensory nerve fibers
and mast cell mediators and cytokines
(Arck et al., 2001, 2003). Thus, NGF
can promote outgrowth of substance P-
positive nerve fibers in this model, for
example, towards mast cells, thereby
building up a network that allows for
increased neurogenic inflammatory
responses upon stress (Peters et al.,
2004). At the same time, NGF alone
can stimulate mast cell degranulation
and release of proinflammatory cyto-
kines by itself (Groneberg et al., 2005;
Raap and Kapp, 2005). Although the
roles for Trk and p75NTR in the control
of this very complex pathobiological
response remain to be elucidated, these
data suggest that both Trk and p75NTR
antagonists may be used for preventing
stress-induced skin and hair growth
abnormalities.
NTs and allergic skin responses. Aller-
gic skin responses like those occurring
in allergic contact dermatitis or atopic
dermatitis depend on neurogenic in-
flammation, but even more on the
production of certain proinflammatory
cytokines (e.g. IL-4; reviewed in Raap
and Kapp, 2005). Accordingly, NGF
and p75NTR expression were shown to
be increased on nerve fibers, Schwann
cells, mast cells, eosinophils, and
keratinocytes in the skin affected by
allergic contact dermatitis, prurigo and
atopic dermatitis, and in the serum of
patients with atopic dermatitis (Grone-
berg et al., 2005; Raap and Kapp,
2005). This increase in NGF may be
responsible for the increased number of
nerve fibers frequently observed in
these skin conditions since NGF ex-
pression was found in a mouse model
of atopic dermatitis, which is also
characterized by increased SPþ nerve
fibers in the skin (reviewed in Raap and
Kapp, 2005).
In epidermal keratinocytes, NGF
increases the expression of the proin-
flammatory cytokine RANTES, known
to play an important role in the devel-
opment of allergic skin infiltrates (Ray-
chaudhuri and Raychaudhuri, 2004)
beyond its role in neurogenic inflam-
mation. Moreover, it was shown
recently that NGF expression correlates
with granularity of eosinophils and that
BDNF via binding to TrkB and p75NTR
can promote eosinophil survival and
migration in atopic individuals (Raap
and Kapp, 2005). Last, the expression
of NT-4 was increased in prurigo
lesions and could be upregulated by
IFN-g injection into the skin (Grewe
et al., 2000), linking again inflamma-
tory cytokines with NT expression,
although the functional relevance of
these observations requires additional
confirmation. These data suggest NTs
as important players in the neuro-
immune network regulating allergic
skin response.
NTs and psoriasis. Psoriasis is a com-
mon chronic inflammatory skin disease
(Raychaudhuri and Raychaudhuri,
2004). Although significant progress
has been made in elucidating the
pathogenesis of psoriasis, the mole-
cular mechanisms that control the
inflammatory and proliferative pro-
cesses in psoriasis are still under
investigation. Cytokines, chemokines,
growth factors, adhesion molecules,
neuropeptides, and T-cell receptors
act in concert to induce unique inflam-
matory and proliferative processes,
typical for psoriasis.
The role of NGF is particularly
relevant in the pathogenesis of
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psoriasis. Immunohistochemical stu-
dies revealed that keratinocytes in
lesional and non-lesional psoriatic
tissues express high levels of NGF,
compared to the controls (Fantini
et al., 1995; Raychaudhuri et al.,
1998). NGF can influence many patho-
logic processes, such as proliferation
of keratinocytes, angiogenesis, T-cell
activation, expression of adhesion
molecules, increase of cutaneous
innervation, and upregulation of
neuropeptides, all known to take place
in psoriasis (Raychaudhuri and
Raychaudhuri, 2004).
Although clinical and laboratory
studies suggest a critical role of NGF
and its receptor system in the inflam-
matory process of psoriasis, direct
evidence had been lacking. To deter-
mine the significance of the NGF/NGF
receptor system in the inflammatory
process of psoriasis, the effects of TrkA
inhibitor K252a was evaluated. In a
double-blinded, placebo-controlled
study, the role of NGF/NGF-R in
psoriasis was addressed in an in vivo
system using the severe combined
immunodeficient mouse–human skin
xenograft model of psoriasis (Ray-
chaudhuri et al., 2004). The trans-
planted psoriatic plaques on the
severe combined immunodeficient
mice were treated with K252a, a high-
affinity NGF receptor blocker. Psoriasis
significantly improved following 2
weeks of therapy and the length of the
rete pegs became significantly
(Po0.01) shorter. A similar improve-
ment in psoriasis was observed by
directly antagonizing NGF with NGF-
neutralizing antibody.
Also, the effects of NGF on en-
dothelial cell biology were reported.
NGF is mitogenic to endothelial cells
and induces intercellular adhesion
molecule expression on these cells
(Raychaudhuri et al., 2001). NGF
effects on endothelial cells could be
inhibited by K252a- and NGF-neutra-
lizing antibody. To substantiate the
effect of NGF on intercellular adhesion
molecule expression, the study was
carried out using skin explants. Normal
human skin samples grafted onto se-
vere combined immunodeficient mice
were injected with NGF and upregula-
tion of intercellular adhesion molecule
on endothelial cells was noticed within
2 hours of injection of NGF. This
induction of intercellular adhesion mo-
lecule was inhibited when NGF and
K252a were injected simultaneously.
However, K252a did not affect the
upregulation of intercellular adhesion
molecule on endothelial cells induced
by substance P (unpublished data).
Taken together, these data suggest
that NGF is involved at least in part in
the pathophysiological control of psor-
iasis, and that inhibition of Trk signal-
ling may be beneficial in psoriasis
treatment. Moreover, preliminary re-
cent data from the murine system
suggest that, vice versa, potent proin-
flammatory cytokines like tumor necro-
sis factor-a, IL-1, and INF-gamma can
upregulate the cutaneous expression of
NGF, NT-3, NT-4, and their p75NTR in
vivo (Bla¨sing et al., 2005), and may
thus contribute to a vicious cycle of
proliferative, antiapoptotic, and proin-
flammatory events that maintain and
promote hyperproliferative, inflamma-
tory skin diseases such as atopic
dermatitis and psoriasis.
Perspectives
In summary, NTs can influence numer-
ous cellular functions in normal and
diseased skin, and NT effects on skin
cell fate (survival, apoptosis, and differ-
entiation) are likely to strongly depend
on multiple signalling pathways that
are activated by NTs in different cells
under different conditions. Despite
substantial progress in understanding
the molecular mechanisms of NT sig-
nalling during the last decade, addi-
tional efforts are required to fully
understand mechanisms controlling
the expression patterns of NTs, their
receptors and co-receptors, as well as
intracellular adaptor molecules in nor-
mal and pathologically altered skin
cells. Moreover, given the multiple
NT target cells in skin (see Figure 2),
and the very complex intracutaneous
signalling loops between these skin cell
populations that NTs feed into and/or
are part of (e.g. via the modulation of
skin nerve fibers, mast cells, melano-
cytes, and Merkel cells, another key
challenge is to dissect direct from
indirect NT-mediated changes in any
given cutaneous tissue compartment
under physiological and pathological
conditions, and to develop adequate
pharmacological tools for targeting
only the clinically desired elements of
NT signalling in the skin. For example,
the systemic administration of NGF for
the treatment of peripheral neuro-
pathies has to cope with the problem
of pain and pruritus induction (see Aloe,
2004), and to be able to dissociate, for
example, the antiapoptotic and prolife-
ration-stimulatory effects of NGF on
epidermal keratinocyte from its (e.g.
mast cell- and substance P-mediated)
proinflammatory ones is an important
challenge. Progress in these neglected
areas of skin and NT research certainly
is a prerequisite for the development of
satisfactory new treatment modalities for
several major pathological skin condi-
tions, such as alopecia, psoriasis, atopic
dermatitis, and tumor growth, based on
the well-targeted modulation of selected
aspects of NT signalling.
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